🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective: Primary objective of the present study was to assess the relati...
Status
Completed
Location
Bio Evaluation Centre, Torrent Pharmaceuticals Ltd.,
Start Date
TBD
Trial ID
NCT01418586
Treatments Being Tested
To asess the efficacy of Uroxatrol, an alpha blocker in men undergoing pros...
Status
Unknown
Location
New York Prostate Institute
Start Date
2005-09
Trial ID
NCT00201630
Treatments Being Tested
Uroxatral (alfuzosin) may not only help BPH symptoms but may also improve s...
Status
Completed
Location
University Hospitals of Cleveland
Start Date
2005-11
Trial ID
NCT00256399
Treatments Being Tested
This study is designed to better understand the effects of effects of stres...
Status
Completed
Location
Mayo Clinic Rochester
Start Date
2013-03
Trial ID
NCT01834729
Patient-based surveys will be conducted to evaluate the drivers of medicati...
Status
Completed
Location
Multiple Locations
Start Date
2009-05
Trial ID
NCT01390870
Treatments Being Tested
Primary: Evaluate the safety and onset of symptom relief using an acute I-P...
Status
Completed
Location
Sanofi-Aventis
Start Date
2003-02
Trial ID
NCT00540891
Treatments Being Tested
We wish to determine the best treatment for expulsion of lower ureteral sto...
Status
Unknown
Location
Hillel Yaffe Medical Center
Start Date
2007-01
Trial ID
NCT00397397
Objective: Primary objective of the present study was to assess the relati...
Status
Unknown
Location
Multiple Locations
Start Date
2024-03-09
Trial ID
NCT06228339
Treatments Being Tested
The purpose of this study is to assess the effect of Alfuzosin in treating ...
Status
Completed
Location
Chesapeake Urology Research Associates
Start Date
2009-06
Trial ID
NCT00893113
Primary Objective: * To assess the sexual function of Benign Prostatic Hyp...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-09
Trial ID
NCT00941343
Treatments Being Tested